The Metabolic Effects of Antipsychotic Medications
نویسندگان
چکیده
منابع مشابه
The metabolic effects of antipsychotic medications.
OBJECTIVES To review current evidence for the hypothesis that treatment with antipsychotic medications may be associated with increased risks for weight gain, insulin resistance, hyperglycemia, dyslipidemia, and type 2 diabetes mellitus (T2DM) and to examine the relation of adiposity to medical risk. METHODS We identified relevant publications through a search of MEDLINE from the years 1975 t...
متن کاملDiabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications
Diabetes is considered to be one of the most psychologically demanding of the chronic medical illnesses and is often associated with several psychiatric disorders. Antipsychotic medications, first introduced in the 1950s, are a vital component of the medical management of several of these psychiatric disorders. These medications are often prescribed by nonpsychiatric physicians. During the peri...
متن کاملMetabolic monitoring for patients treated with antipsychotic medications.
OBJECTIVES Metabolic side effects of antipsychotic treatment include weight gain, dyslipidemia and increased susceptibility to diabetes. Patients with schizophrenia have increased coronary heart disease mortality and reduced life expectancy. There is an urgent clinical need to monitor antipsychotic-treated patients for metabolic disturbance. Our objectives were to review published international...
متن کاملHyperglycemia and antipsychotic medications.
Type 2 diabetes mellitus and impaired glucose tolerance are associated with antipsychotic treatment. Risk factors for type 2 diabetes and impaired glucose tolerance include abdominal adiposity, age, ethnic status, and certain neuropsychiatric conditions. While impaired glucose metabolism was first described in psychotic patients prior to the introduction of antipsychotic medications, treatment ...
متن کاملEffects of antipsychotic medications on appetite, weight, and insulin resistance.
Although clozapine, olanzapine, and other atypical antipsychotic drugs (APDs) have fewer extrapyramidal side effects, they have serious metabolic side effects such as substantial weight gain, intra-abdominal obesity, and type 2 diabetes mellitus. Given that most patients with mental disorders face chronic, even life-long, treatment with APDs, the risks of weight gain/obesity and other metabolic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Canadian Journal of Psychiatry
سال: 2006
ISSN: 0706-7437,1497-0015
DOI: 10.1177/070674370605100803